These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17227711)

  • 1. Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.
    Xing C; Wang L; Tang X; Sham YY
    Bioorg Med Chem; 2007 Mar; 15(5):2167-76. PubMed ID: 17227711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists.
    Rega MF; Reed JC; Pellecchia M
    Bioorg Chem; 2007 Apr; 35(2):113-20. PubMed ID: 16996562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
    Zheng CH; Yang H; Zhang M; Lu SH; Shi D; Wang J; Chen XH; Ren XH; Liu J; Lv JG; Zhu J; Zhou YJ
    Bioorg Med Chem Lett; 2012 Jan; 22(1):39-44. PubMed ID: 22172701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
    Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
    Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
    Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rise of the selective inhibitors of anti-apoptotic Bcl-2 family proteins.
    Han L; Wang R
    ChemMedChem; 2013 Sep; 8(9):1437-40. PubMed ID: 23907935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
    Raghav PK; Verma YK; Gangenahalli GU
    Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activities of new di- and trimeric quinoline derivatives.
    Broch S; Hénon H; Debaud AL; Fogeron ML; Bonnefoy-Bérard N; Anizon F; Moreau P
    Bioorg Med Chem; 2010 Oct; 18(19):7132-43. PubMed ID: 20800501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and activity evaluation of selective inhibitors of anti-apoptotic Bcl-2 proteins: The effects on the selectivity of the P1 pockets in the active sites.
    Wang M; Tian W; Wang C; Lu S; Yang C; Wang J; Song Y; Zhou Y; Zhu J; Li Z; Zheng C
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5207-5211. PubMed ID: 27712939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng.
    Sathishkumar N; Sathiyamoorthy S; Ramya M; Yang DU; Lee HN; Yang DC
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):685-92. PubMed ID: 21919598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR.
    Petros AM; Huth JR; Oost T; Park CM; Ding H; Wang X; Zhang H; Nimmer P; Mendoza R; Sun C; Mack J; Walter K; Dorwin S; Gramling E; Ladror U; Rosenberg SH; Elmore SW; Fesik SW; Hajduk PJ
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6587-91. PubMed ID: 20870405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A.
    Kim KM; Giedt CD; Basañez G; O'Neill JW; Hill JJ; Han YH; Tzung SP; Zimmerberg J; Hockenbery DM; Zhang KY
    Biochemistry; 2001 Apr; 40(16):4911-22. PubMed ID: 11305906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
    Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
    EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and expression analyses of anti-apoptotic Bcl-2-like genes NR-13, Mcl-1, Bcl-X1, and Bcl-X2 in Atlantic cod (Gadus morhua).
    Feng CY; Rise ML
    Mol Immunol; 2010 Jan; 47(4):763-84. PubMed ID: 19923001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 family proteins as targets for anticancer drug design.
    Huang Z
    Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
    Becattini B; Kitada S; Leone M; Monosov E; Chandler S; Zhai D; Kipps TJ; Reed JC; Pellecchia M
    Chem Biol; 2004 Mar; 11(3):389-95. PubMed ID: 15123268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.